I'm trying to think of another treatment that is pan-genotypic (G1-6) HCV treatment offered for 8 weeks in all genotypes.
Or one with higher response rates in G-1.
Sure, price will be important, but overall, which treatment would one put above G/P?
Harvoni? How is it for all other genotypes?
Sov/Velpatasvir is very very good, but for the most part won't be used with G-1, nor is it labeled for 8 weeks.
The Gilead triple? Only to be used as salvage, higher AE's, failed to meet endpoint objectives 8 weeks/non-inferior to Sov/Vel.
A few years ago the world "knew" that a nuke was necessary.
This treatment seems like a huge success to me.
